Display options
Share it on

Paediatr Child Health. 2010 Nov;15(9):603-15.

Antifungal agents for the treatment of systemic fungal infections in children.

Paediatrics & child health

[Article in French]
Ud Allen

PMID: 22043144 PMCID: PMC3009569

Abstract

Traditionally, the mainstay of systemic antifungal therapy has been amphotericin B deoxycholate (conventional amphotericin B). Newer agents have been developed to fulfill special niches and to compete with conventional amphotericin B by virtue of having more favourable toxicity profiles. Some agents have displaced conventional amphotericin B for the treatment of specific fungal diseases. For example, voriconazole has emerged as the preferred treatment for invasive pulmonary aspergillosis. This notwithstanding, conventional amphotericin B remains a useful agent for the treatment of paediatric fungal infections. Knowledge of the characteristics of the newer agents is important, given the increasing numbers of patients who are being treated with these drugs. Efforts need to be directed at research aimed at generating paediatric data where these are lacking. The antifungal agents herein described are most often used as monotherapy regimens because there is no uniform consensus on the value of combination therapy, except for specific scenarios.

Keywords: Amphotericin B; Antifungal therapy; Echinocandins; Triazoles

References

  1. Cochrane Database Syst Rev. 2004;(1):CD003850 - PubMed
  2. Blood. 2000 Sep 15;96(6):2055-61 - PubMed
  3. J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i17-i22 - PubMed
  4. Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):325-9 - PubMed
  5. Clin Infect Dis. 2002 Aug 15;35(4):359-66 - PubMed
  6. N Engl J Med. 2007 Jun 14;356(24):2483-95 - PubMed
  7. Clin Infect Dis. 2006 Apr 15;42(8):1171-8 - PubMed
  8. Clin Infect Dis. 2003 Jun 1;36(11):1445-57 - PubMed
  9. Antimicrob Agents Chemother. 2008 Apr;52(4):1396-400 - PubMed
  10. Antimicrob Agents Chemother. 2005 Aug;49(8):3317-24 - PubMed
  11. Pediatr Infect Dis J. 2006 Dec;25(12):1110-5 - PubMed
  12. J Toxicol Clin Toxicol. 1990;28(3):371-8 - PubMed
  13. Transpl Infect Dis. 2002 Dec;4(4):195-200 - PubMed
  14. Pediatr Infect Dis J. 2005 Feb;24(2):167-74 - PubMed
  15. Pediatr Infect Dis J. 2005 Oct;24(10):921-2 - PubMed
  16. N Engl J Med. 2002 Dec 19;347(25):2020-9 - PubMed
  17. N Engl J Med. 2002 Aug 8;347(6):408-15 - PubMed
  18. Pediatr Infect Dis J. 1998 Feb;17(2):146-8 - PubMed
  19. Clin Infect Dis. 2004 Nov 15;39(10):1407-16 - PubMed
  20. N Engl J Med. 2004 Sep 30;351(14):1391-402 - PubMed
  21. Clin Infect Dis. 2008 Feb 1;46(3):327-60 - PubMed
  22. Pediatr Infect Dis J. 2002 Mar;21(3):240-8 - PubMed
  23. Pharmacotherapy. 1990;10(5):341-8 - PubMed
  24. Clin Infect Dis. 2006 Jul 15;43(2):215-22 - PubMed
  25. Curr Opin Pediatr. 2005 Feb;17(1):78-87 - PubMed
  26. Clin Infect Dis. 2007 Dec 15;45(12):1610-7 - PubMed
  27. Clin Pharmacokinet. 1997 Jul;33(1):52-77 - PubMed
  28. Antimicrob Agents Chemother. 2002 Aug;46(8):2554-63 - PubMed
  29. Antimicrob Agents Chemother. 1997 Sep;41(9):1944-8 - PubMed
  30. Infect Dis Clin North Am. 2003 Mar;17(1):159-91, ix - PubMed
  31. Antimicrob Agents Chemother. 1998 Feb;42(2):404-8 - PubMed
  32. Clin Ther. 2003 May;25(5):1321-81 - PubMed
  33. Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):77-82 - PubMed
  34. Pediatr Infect Dis J. 1999 Aug;18(8):702-8 - PubMed
  35. Pediatr Clin North Am. 2005 Jun;52(3):895-915, viii - PubMed
  36. Bone Marrow Transplant. 1999 Nov;24(10):1089-93 - PubMed

Publication Types